Simon R. Junankar is an oncologist working at St Vincent's Clinical Campus, UNSW Sydney, in Sydney, NSW. His clinical focus is on breast cancer, including triple-negative breast cancer. This is a type of breast cancer where the usual hormone and HER2 targets aren’t present, so treatment planning often needs a careful, tailored approach.
In an oncology clinic, the day-to-day work is about more than one scan or one treatment. It’s usually a mix of helping people understand what’s going on, checking how well treatment is working, and adjusting plans when needed. For breast cancer patients, that can mean discussing treatment options, timing, side effects, and what follow-up care might look like over time.
Triple-negative breast cancer can be tough. At times, it may be treated with a combination of chemotherapy and other therapies depending on the stage and overall health. For many people, the biggest challenge is managing the emotional and practical side of treatment, not just the medical steps. Having a clear plan and steady support matters, especially when appointments, test results, and treatment cycles come one after another.
Simon R. Junankar’s work with breast cancer patients sits within this wider oncology care. That includes reviewing results, looking at changes across investigations, and making sure treatment choices line up with the patient’s situation. In many cases, the goal is to improve outcomes while also keeping quality of life in mind. Decisions can be complex, so communication and clarity are important.
Based in Sydney, care at St Vincent's Clinical Campus connects patients with a broader hospital team. Oncology care often involves coordination with other specialists, along with nursing and allied health support. Over time, treatment can shift, and follow-up keeps an eye on recovery, late effects, and any signs that need attention.
Public details about years of experience, formal education, and research or clinical trial involvement aren’t listed here. The information that is available centres on his oncology specialty and his focus on breast cancer, especially triple-negative breast cancer.
For patients and families, that focus can offer a more direct pathway into breast cancer care, with the kind of attention that matters when the diagnosis is specific and the treatment plan needs to be just right.
